A dual‑center study in Ther Adv Med Oncol evaluated the Systemic Inflammation‑Nutrition Index (SINI) as a predictor of pathological response and relapse‑free survival in locally advanced #GIST treated with neoadjuvant imatinib.
buff.ly/fKecUtx
#Sarcoma #MedicalOncology #TargetedTherapy

Fabrication of MPI-traceable alginate magnetic millirobots with multimodal selective-locomotion and heating capabilities

This #IJEM study presents MPI-traceable alginate magnetic #Millirobots enabling integrated locomotion, magnetic heating, and real-time tracking, advancing #TargetedTherapy and minimally invasive #Biomedical applications.

#OpenAccess: doi.org/10.1088/2631...

Ferroptosis by nanomaterials targeting cancer stem cells
www.scienceopen.com/hosted-docum...
#Ferroptosis #Nanomaterials #CancerStemCells #TargetedTherapy #CancerResearch

Estrogen receptor-targeted agents in breast cancer
www.scienceopen.com/hosted-docum...
#BreastCancer #EstrogenReceptor #TargetedTherapy #HormoneTherapy #Oncology

By targeting how tumour cells repair #DNA, this approach could help extend the life of treatments patients are already taking, instead of constantly moving to harsher options. #Oncology #TargetedTherapy #TCSC

PROTAC technology for prostate cancer treatment
www.scienceopen.com/hosted-docum...
#PROTAC #ProstateCancer #TargetedTherapy #ProteinDegradation #Oncology

Next-generation therapies to outsmart drug-resistant lung cancer The Gray Lab is developing next-gen therapies, including protein degraders and "dual-grip" inhibitors, to overcome drug resistance in lung cancer.

Stanford’s Gray Lab is designing the next wave of EGFR‑targeted drugs for lung cancer, from protein “degraders” that destroy EGFR to dual‑grip covalent inhibitors that hold on so tightly resistance has nowhere to go. #LungCancer #TargetedTherapy #TCSC
med.stanford.edu/cancer/about...

Antibody Therapeutics (IF=4.5, Oxford University Press)
🔹 Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody–drug conjugates
academic.oup.com/abt/advance-...
#ADC #TROP2 #CancerResearch #TargetedTherapy

FDA Grants Accelerated Approval to Zongertinib (Hernexeos) for HER2-Mutated NSCLC The U.S. Food and Drug Administration granted accelerated approval to zongertinib (Hernexeos) for the treatment of adults with HER2-mutated unresectable or metastatic nonsquamous non-small cell lung c...

The FDA has cleared the first once‑daily oral targeted therapy for treatment‑naïve HER2‑mutant advanced NSCLC, giving patients an option that avoids infusion chairs and starts as soon as the mutation is found. #LungCancer #TargetedTherapy #TCSC
www.oncologynewscentral.com/drugs/info/f...

🧬 4 inhibidores clave de #PARP en el tratamiento del cáncer de próstata
💊 Terapia dirigida
🎯 Mutaciones #BRCA
🔗 Tratamientos combinados

#CáncerDePróstata #PARPInhibitors #MedicinaDePrecisión #PrecisionMedicine #TerapiaDirigida #TargetedTherapy #HRR #DNARepair #DengYueMedicinasEnHongKong

ONCOassist Universal Link Opening ONCOassist app...

🔗 Read more: bit.ly/ONCOnews-19M...

#ONCOnews #OncoAlert #OncEd #OvarianCancer #CancerResearch #Oncology #PrecisionMedicine #PersonalizedMedicine #CompanionDiagnostics #Biomarkers #TargetedTherapy #CancerCare #OncologyNews #ClinicalTrials #DrugDevelopment #FDAApproval #PharmaNews #MedTech

What Are Targeted Cancer Therapies? CU Anschutz Cancer Center member Urs Weber, MD, walks us through a family of focused treatments that can block or slow cancer’s growth.

Targeted cancer therapies home in on specific weaknesses in cancer cells, often sparing more healthy tissue than traditional chemotherapy and changing outcomes in many tumour types. #targetedtherapy #cancer #TCSC
news.cuanschutz.edu/cancer-cente...

Synapse: Your Connection to our MSK Authors
Meet: Elisa De Stanchina
Research Focus: Res Facilities; Lab Member

Trastuzumab deruxtecan resistance via loss of HER2 expression and binding
synapse.mskcc.org/synapse/work...

#TrastuzumabDeruxtecan #HER2
#BreastCancerResearch #TargetedTherapy #Oncology

🔷 However, the combination did not improve overall survival (OS) (15.0 vs 17.9 months; HR 1.15) and was associated with higher grade 3–4 adverse events (66.9% vs 38.3%).

🔗 Read more: bit.ly/ONCOnews13-M...

#ONCOnews #OncoAlert #OncEd #Oncology #CancerResearch #Immunotherapy #TargetedTherapy

China impulsa la innovación en oncología.
📊 Descubre en este póster 5 medicamentos innovadores para el cáncer de mama.

#CáncerDeMama #Dalpiciclib #Pyrotinib #Chidamide #Envafolimab #DisitamabVedotin #HER2 #HER2Positive #TargetedTherapy #ADC #TerapiasInnovadoras #DengYueMedicinasEnHongKong

in4u.org/china-russia... Russia and China report early success using a Chinese targeted therapy for rare head‑and‑neck cancers. Their partnership now expands into CAR‑T, TIL, and mRNA research, with a new mirror lab planned in Moscow.

#ChinaRussiaOncology #CancerResearch #TargetedTherapy

🌍 Cada año se diagnostican ~20 millones de nuevos casos de cáncer en el mundo.

Los avances en detección temprana, terapias dirigidas e inmunoterapia están mejorando el tratamiento.

💬 ¿Qué medicamento contra el cáncer quieres que expliquemos después?

#immunotherapy #targetedtherapy #DengYueMed

🔬🌍 Revolutionizing healthcare with nano-enabled smart drug delivery! Our review explores the latest advances in targeted therapy and theranostics within the One Health framework. 🦟🌟

📚Read more: link.springer.com/article/10.1... 🔗

#Nanomedicine #OneHealth #TargetedTherapy

Stories like this highlight the potential of targeted therapies to change outcomes and spare patients from more invasive treatments. The future of oncology is becoming increasingly personalized.

#TargetedTherapy #CancerResearch #TCSC

ONCOassist Universal Link Opening ONCOassist app...

🔷 The LITESPARK-022 Phase 3 data suggests added benefit from combining PD-1 blockade with HIF-2α inhibition in the post-nephrectomy setting.

🔗 Read more: bit.ly/ONCOnews02-M...

#ONCOnews #OncoAlert #OncEd #Oncology #CancerResearch #Immunotherapy #TargetedTherapy #RenalCellCarcinoma #KidneyCancer

Zongertinib Approved by FDA for HER2+ NSCLC Zongertinib receives FDA accelerated approval for advanced HER2-mutant NSCLC, expanding targeted treatment options.

Zongertinib Receives FDA Accelerated Approval in HER2-Mutant NSCLC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #NSCLC #MedEd #MedOnc #MedNews #LungCancer #HER2 #TargetedTherapy #FDAApproval

TGF-β in tumor development and progression: mechanisms and therapeutics - Molecular Biomedicine Transforming growth factor beta (TGF-β) is a pleiotropic cytokine and participates in multiple cellular processes, such as cell development, proliferation, epithelial mesenchymal transition (EMT), and...

#Review
#TGF-β in #tumor development and progression: mechanisms and therapeutics doi.org/10.1186/s435...

Authored by researchers from #SoochowUniversity

#signaling #TME #Metastasis #immunity #TargetedTherapy

5
A comprehensive overview of signaling pathways in colorectal cancer, spanning pathogenesis to targeted therapy.
A roadmap for translational research.
doi.org/10.1038/s413...
#ColorectalCancer #SignalTransduction #CancerPathogenesis #TargetedTherapy #OncologyReview

Colon cancer research is advancing across clinical trials, tumor biology, metabolism, immunity and single-cell genomics.
Explore the latest discoveries from Signal Transduction and Targeted Therapy:
www.nature.com/sigtrans/
#ColonCancer #ColorectalCancer #SignalTransduction #TargetedTherapy

New review - The treatment landscape for advanced gastric/GEJ adenocarcinoma is rapidly evolving. Upfront ICIs, targeted agents, and biomarker‑guided strategies are reshaping first‑line, maintenance, and sequential therapy.
🔗 buff.ly/22B0Oz0
#GastricCancer #GEJ #Immunotherapy #TargetedTherapy

Support free patient education — donate today. 💙

#LungCancer #Biomarkers #TargetedTherapy

Support free patient education — donate today. 💙

#LungCancer #TargetedTherapy #PrecisionMedicine

Synapse: Your Connection to our MSK Authors
Meet: Fernando Costa Santini
Research Focus: Medicine; Assistant Attending

A phase II study of cabozantinib in patients with MET-altered lung cancers
synapse.mskcc.org/synapse/work...

#LungCancer #METAltered
#TargetedTherapy #PrecisionOncology

Lung Cancer Targeted Therapies OncTalk 2026 {{MetaTags.description}}

Register:
give.cancergrace.org/event/lung-c...

Support free patient education — donate today. 💙

#LungCancer #NSCLC #TargetedTherapy